In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

CoreWellness founder Bryant Williams, Neighborhood Development Center’s Renay Dossman, Medtronic’s Geoff Martha and Patti and ...

There is growing appetite in Silicon Valley for the legally murky and morally frowned upon practice of embryo-editing. This ...

Crispr Therapeutics (CRSP) quickly rose 1.3% amid some takeover speculation. Crispr (CRSP) is said to have attracted takeover interest, according to traders, who cited a Betaville "uncooked' alert ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?